Clinical Trials Browser

Phase 1 × Unknown × Lymphoid × Clear all

NCT04637763 2025-03-24

CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER)

Phase 1 Unknown

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT04977167 2024-10-10

Clinical Trial of HG146 Administered to Subjects with Advanced Solid Tumors or Lymphoma

Phase 1 Unknown

Lymphoma

NCT05650580 2024-05-14

TR115 in Patients With Relapsed / Refractory Non-Hodgkin's Lymphoma or Advanced Solid Tumors

Phase 1 Unknown

Lymphoma, Non-Hodgkin, Recurrence

NCT05052528 2024-05-13

Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Phase 1 Unknown

Lymphoma, Large B-Cell, Diffuse

NCT05606380 2024-04-16

A Phase I Study to Investigate the Safety, Tolerability and PK of HLX60 (Anti-GARP Monoclonal Antibody) in Subjects With Solid Tumors or Lymphoma

Phase 1 Unknown

Lymphoma

NCT06206902 2024-02-23

F01 in the Treatment of Relapsed/Refractory Non-hodgkin's Lymphoma

Phase 1 Unknown

Lymphoma, Non-Hodgkin

NCT04137900 2024-02-05

Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies

Phase 1 Unknown

DermatologicLymphoidThoracic

Carcinoma, Non-Small-Cell Lung, Lymphoma, Melanoma, Neoplasm Metastasis

NCT05150405 2024-01-23

A Phase Ia Clinical Study of QLF31907 Injection in Patients With Advanced Malignant Tumors

Phase 1 Unknown

Lymphoma, Non-Hodgkin

NCT06209671 2024-01-17

INS19 CAR-T Cells for the Treatment of Relapsed or Refractory Acute B Lymphoblastic Leukemia

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT05420493 2024-01-05

Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma

Phase 1 Unknown

Lymphoma, Non-Hodgkin

NCT05460767 2023-12-29

Safety, Tolerability and Preliminary Efficacy of IBI363 in Subjects With Advanced Solid Tumors or Lymphoma

Phase 1 Unknown

Lymphoma

NCT06164327 2023-12-11

Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Phase 1 Unknown

Lymphoma, Large B-Cell, Diffuse

NCT04599556 2023-12-06

Clinical Trial for the Safety and Efficacy of Anti-CD7 CAR-T Cell Therapy for Patients With Relapsed or Refractory CD7 Positive Hematological Malignancy

Phase 1 Unknown

LymphoidOther hematologic neoplasm

CD7+ Acute Leukemia

NCT05113069 2023-12-06

A Study of SHR-A1912 for Injection in Patients With B Cell Lymphomas

Phase 1 Unknown

Lymphoma, B-Cell

NCT03064269 2023-11-29

CAR-T Therapy for Central Nervous System B-cell Acute Lymphocytic Leukemia

Phase 1 Unknown

Burkitt Lymphoma

NCT05115292 2023-11-09

A First-in-Human, Phase 1 Dose-Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BJ-005 in Patients With Advanced Solid Tumor or Lymphoma

Phase 1 Unknown

Lymphoma

NCT06125106 2023-11-09

Prospective, Single-arm, Multicenter Clinical Study on Haploidentical Hematopoietic Stem Cell Transplantation in Patients With MRD Positive CD19+ALL Treated With Conditioning Regimens Containing Blinatumomab

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04712864 2023-10-03

Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell Lymphoma

Phase 1 Unknown

Lymphoma, T-Cell

NCT04693676 2023-09-28

A Study of C-CAR039 Treatment in Subjects With r/r NHL Subjects Non-Hodgkin's Lymphoma

Phase 1 Unknown

Lymphoma, B-Cell

NCT04825496 2023-09-21

Clinical Study of ssCART-19 Cells in Patients With CD19 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05781386 2023-09-21

A Phase I Trial of SIM1811-03 in Subjects With Advanced Tumors

Phase 1 Unknown

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT03709914 2023-09-15

Pediatric_PK

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05564806 2023-09-07

Study of YH004 (4-1BB Agonist Antibody) in Advanced Solid Tumors And Relapsed Or Refractory Non-Hodgkin Lymphoma

Phase 1 Unknown

LymphoidOther solid neoplasm

Advanced Solid Tumors

NCT05296772 2023-09-06

Phase 1 First-in-human Study of JS014

Phase 1 Unknown

Lymphoma, Neoplasms, Neoplasms, Experimental

NCT05005299 2023-08-01

VICTORY

Phase 1 Unknown

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04763083 2023-07-07

First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies

Phase 1 Unknown

DermatologicLymphoidOther hematologic neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Lymphoma, Follicular, Melanoma, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT05900089 2023-06-12

Efficacy and Safety of SHR0302 in Patients With Relapsed/Refractory Peripheral T/NK Cell Lymphoma

Phase 1 Unknown

Lymphoma, T-Cell, Peripheral

NCT05487651 2023-05-18

ANCHOR2

Phase 1 Unknown

LymphoidOther hematologic neoplasmSarcoma

Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

NCT04356846 2023-05-01

A Phase I Study of LP-108 in Patients With Relapsed or Refractory B-cell Lymphoma

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

NCT03510767 2023-04-14

A Study of TQ-B3525 on Tolerance and Pharmacokinetics

Phase 1 Unknown

Lymphoma, Recurrence

NCT05495035 2023-03-02

Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALL

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04309084 2023-02-16

Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma

Phase 1 Unknown

LymphoidPlasma cell

Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, Hemorrhagic Disorders, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Neoplasm, Residual, Hemostatic Disorders, Neoplasms, Plasma Cell

NCT05727683 2023-02-14

CD19-targeted CAR T Cells for Patients With Relapsed or Refractory in B-cell Acute Lymphoblastic Leukemia

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04381741 2023-02-06

CICPD

Phase 1 Unknown

Lymphoma, Large B-Cell, Diffuse

NCT04887025 2023-02-06

Exploratory Study of a Novel Oncolytic Vaccinia Virus RGV004 in the Treatment of Refractory/Relapsed B-cell Lymphoma

Phase 1 Unknown

Recurrence, Lymphoma, B-Cell

NCT05585996 2023-02-06

Exploratory Clinical Study of CD19-targeted CAR-T and CAR-DC in the Treatment of Relapsed and Refractory B-cell Lymphoma

Phase 1 Unknown

Recurrence, Lymphoma, B-Cell

NCT05667155 2023-02-06

Clinical Study of Cord Blood-derived CAR NK Cells Targeting CD19/CD70 in Refractory/Relapsed B-cell Non-Hodgkin Lymphoma

Phase 1 Unknown

Lymphoma, B-Cell

NCT05381181 2023-01-27

Safety and Efficacy Evaluation of Next-generation CD19-UCART

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05691153 2023-01-19

ThisCART19A for B-NHL Relapsed After Auto-CAR T

Phase 1 Unknown

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT05679687 2023-01-11

ThisCART19A Bridging to alloHSCT for R/R B-ALL

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03775525 2022-12-23

GEN602

Phase 1 Unknown

BreastDermatologicGastrointestinalHead & NeckLymphoidSarcoma

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Basal Cell, Colonic Neoplasms, Lymphoma, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Lymphoma, T-Cell, Cutaneous

NCT05415098 2022-11-16

Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas

Phase 1 Unknown

GastrointestinalHead & NeckLymphoidOther solid neoplasmSarcomaThoracic

Nasopharyngeal Carcinoma, Lymphoma, Non-Hodgkin, Mesothelioma, Sarcoma, Stomach Neoplasms, Lymphoma, B-Cell

NCT05596266 2022-10-27

CD5 CAR-T Therapy for Refractory/Relapsed CD5+ T-cell Acute Lymphoblastic Leukemia

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT04118868 2022-10-12

Pembrolizumab Administered Via the Sofusa® DoseConnect™ in Patients With Relapsed/Refractory Cutaneous T-cell Lymphoma.

Phase 1 Unknown

DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

NCT05569057 2022-10-07

A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma

Phase 1 Unknown

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT05557903 2022-09-28

Phase Ⅰ Clinical Study of Anti-CD52 Monoclonal Antibody in NHL and T-PLL

Phase 1 Unknown

Lymphoma, Non-Hodgkin, Recurrence, Lymphoma, T-Cell

NCT04684472 2022-09-26

Modified CD19 CAR-T in Patients With Relapsed or Refractory CD19+ B-cell Malignancies

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, B-Cell

NCT05458180 2022-07-14

CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma

Phase 1 Unknown

Lymphoma, T-Cell, Peripheral

NCT05453669 2022-07-12

Clinical Study of the Efficacy of CD19-CAR-DNT Cells in the Treatment of Relapsed/Refractory B-cell NHL

Phase 1 Unknown

Lymphoma, B-Cell

NCT05212584 2022-07-06

CD7 CAR-T Cell Treatment of Relapsed/Refractory CD7+ T -Acute Lymphoblastic Leukemia/ Lymphoma

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Recurrence, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma